COMPETITIVE STRATEGIES OF BIOTECHNOLOGY FIRMS: IMPLICATIONS FOR U.S. AGRICULTURE

Brett D. Begemann

Journal of Agricultural and Applied Economics, 1997, vol. 29, issue 01, 6

Abstract: The agricultural biotechnology industry has evolved from a focus on outstanding science to a more mature phase where firms focus on near-term products and building businesses. Understanding complex relationships and distribution channels and a global perspective are crucial to commercialization. Yet, leading-edge technology and early identification of key traits will be critical to developing superior products that ensure competitiveness in the marketplace. Monsanto is organizing around a life sciences model where seed, crop chemicals, pharmaceuticals, and food ingredient businesses will exploit mutual synergies driven by basic science and discovery.

Keywords: Research; and; Development/Tech; Change/Emerging; Technologies (search for similar items in EconPapers)
Date: 1997
References: Add references at CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
https://ageconsearch.umn.edu/record/15540/files/29010117.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:joaaec:15540

DOI: 10.22004/ag.econ.15540

Access Statistics for this article

More articles in Journal of Agricultural and Applied Economics from Southern Agricultural Economics Association Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().